Veterinary Medicines

PARVOERYSIN emulsione iniettabile

Authorised
  • Erysipelothrix rhusiopathiae, serotype 1, strain 1-203, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-II, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-5, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
Download as PDF

Product identification

Medicine name:
PARVOERYSIN emulsione iniettabile
Active substance:
  • Erysipelothrix rhusiopathiae, serotype 1, strain 1-203, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-II, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-5, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Erysipelothrix rhusiopathiae, serotype 1, strain 1-203, Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-II, Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-5, Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
    4.00
    log2 haemagglutination inhibiting unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 24/05/2022
Download